Dr Keimun A Slaughter, MD | |
1072 Troy Schenectady Rd, Latham, NY 12110-1019 | |
(518) 786-7000 | |
Not Available |
Full Name | Dr Keimun A Slaughter |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 15 Years |
Location | 1072 Troy Schenectady Rd, Latham, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073756649 | NPI | - | NPPES |
04156718 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207YS0123X | Otolaryngology - Facial Plastic Surgery | 279519 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Albany Medical Center Hospital | Albany, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Edwin F Williams Iii Md Facial Plastic Surgery Pllc | 8628982410 | 4 |
News Archive
Scientists, physicians, consumers and environmental health advocates today responded to an FDA staff presentation on progress of their review of bisphenol A (BPA), a synthetic sex hormone linked to cancer, diabetes, heart problems and other illness. Congressmen Henry Waxman and Bart Stupak asked for FDA to review their evaluation of BPA.
Coronary bypass surgery may carry less risk of serious complications if stents coated with a drug that suppresses cell growth are used in the procedure rather than bare-metal stents, UT Southwestern Medical Center researchers and colleagues have found.
Immunologists and oncologists are harnessing the body's immune system to fight cancers and other diseases with adoptive cell transfer techniques. In a normal immune response, a type of white blood cell known as T cells are instructed by another kind of immune cell called an antigen-presenting cell (APC) to expand their numbers and stay alive.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that the clinical utility of the PROGENSA(R) PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline's REDUCE trial of dutasteride. The results demonstrate that PCA3 can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy and can predict the risk of having an aggressive cancer.
› Verified 5 days ago
Entity Name | Edwin F Williams Iii Md Facial Plastic Surgery Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679565410 PECOS PAC ID: 8628982410 Enrollment ID: O20091202000472 |
News Archive
Scientists, physicians, consumers and environmental health advocates today responded to an FDA staff presentation on progress of their review of bisphenol A (BPA), a synthetic sex hormone linked to cancer, diabetes, heart problems and other illness. Congressmen Henry Waxman and Bart Stupak asked for FDA to review their evaluation of BPA.
Coronary bypass surgery may carry less risk of serious complications if stents coated with a drug that suppresses cell growth are used in the procedure rather than bare-metal stents, UT Southwestern Medical Center researchers and colleagues have found.
Immunologists and oncologists are harnessing the body's immune system to fight cancers and other diseases with adoptive cell transfer techniques. In a normal immune response, a type of white blood cell known as T cells are instructed by another kind of immune cell called an antigen-presenting cell (APC) to expand their numbers and stay alive.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that the clinical utility of the PROGENSA(R) PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline's REDUCE trial of dutasteride. The results demonstrate that PCA3 can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy and can predict the risk of having an aggressive cancer.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Keimun A Slaughter, MD 2301 Erwin Rd, Durham, NC 27710-0001 Ph: () - | Dr Keimun A Slaughter, MD 1072 Troy Schenectady Rd, Latham, NY 12110-1019 Ph: (518) 786-7000 |
News Archive
Scientists, physicians, consumers and environmental health advocates today responded to an FDA staff presentation on progress of their review of bisphenol A (BPA), a synthetic sex hormone linked to cancer, diabetes, heart problems and other illness. Congressmen Henry Waxman and Bart Stupak asked for FDA to review their evaluation of BPA.
Coronary bypass surgery may carry less risk of serious complications if stents coated with a drug that suppresses cell growth are used in the procedure rather than bare-metal stents, UT Southwestern Medical Center researchers and colleagues have found.
Immunologists and oncologists are harnessing the body's immune system to fight cancers and other diseases with adoptive cell transfer techniques. In a normal immune response, a type of white blood cell known as T cells are instructed by another kind of immune cell called an antigen-presenting cell (APC) to expand their numbers and stay alive.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that the clinical utility of the PROGENSA(R) PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline's REDUCE trial of dutasteride. The results demonstrate that PCA3 can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy and can predict the risk of having an aggressive cancer.
› Verified 5 days ago
Mr. Daniel Dayeon Lee, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1072 Troy Schenectady Rd, Latham, NY 12110 Phone: 518-786-7000 | |
Dr. Edwin Williams, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1072 Troy Schenectady Rd, Latham, NY 12110 Phone: 518-786-7000 Fax: 518-786-1160 |